» Articles » PMID: 17097843

Multidetector Spiral CT Renal Angiography in the Diagnosis of Renal Artery Fibromuscular Dysplasia

Overview
Journal Eur J Radiol
Specialty Radiology
Date 2006 Nov 14
PMID 17097843
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to evaluate the role and detection rate of multidetector spiral CT renal angiography (CTA) as compared with conventional angiography (CA), the commonly accepted gold standard, in the diagnosis of renal artery fibromuscular dysplasia (FMD). In addition, the role of CTA reconstructions (multiplanar reformatted images (MPR), maximum intensity projections (MIP) and shaded-surface display (SSD)) in the detection of FMD was also evaluated.

Materials And Methods: CTA results were retrospectively reviewed in 21 hypertensive patients with CA-proven FMD. Clinical indications for referral included resistant hypertension (requiring greater than three antihypertensive medications), labile hypertension, hypertension in combination with renal impairment and the presence of abdominal bruits in the context of systemic hypertension. In some cases, these clinical indications were supplemented by positive results in other tests, including plasma renin assay, captopril scintigraphy and/or Doppler ultrasound. The findings of CA in these 21 patients were compared to CTA.

Results: Mean patient age was 62.33+14.32 years (range 24-85 years). CTA identified all 42 main renal arteries (100%) and all 10 accessory renal arteries (100%) visualized on CA. In the diagnosis of FMD, CTA detected all 40 (100%) lesions detected by CA. No single CTA reconstruction technique was able to detect all lesions noted on corresponding CA, however, upon review of all CTA reconstructions (MPR, MIP and SSD) in each case, every lesion was correctly identified by CTA.

Conclusion: Our experience suggests that CTA is a non-invasive, reliable and accurate method for the diagnosis of renal artery fibromuscular dysplasia. Moreover, in our experience CTA has many advantages as a diagnostic screening tool over CA, including accessibility, speed, lower complication profile, versatility and cost-effectiveness. CTA shows great potential as a guiding tool for directing subsequent procedures such as CA+balloon angioplasty.

Citing Articles

Evidence for routine brain-to-pelvis imaging and antiplatelet therapy in patients diagnosed with fibromuscular dysplasia.

Ostergaard M, Hjort N, Buus N, Reinhard M J Clin Hypertens (Greenwich). 2024; 26(8):890-901.

PMID: 39012329 PMC: 11301438. DOI: 10.1111/jch.14865.


Imaging studies in pediatric fibromuscular dysplasia (FMD): a single-center experience.

Louis R, Levy-Erez D, Cahill A, Meyers K Pediatr Nephrol. 2018; 33(9):1593-1599.

PMID: 29869115 PMC: 6082421. DOI: 10.1007/s00467-018-3983-6.


A Unique Case of Renovascular Hypertension due to Fibromuscular Dysplasia in an Extra-renal Artery.

Sakuma I, Saito J, Matsuzawa Y, Omura M, Matsui S, Nishikawa T Intern Med. 2018; 57(18):2689-2694.

PMID: 29709926 PMC: 6191605. DOI: 10.2169/internalmedicine.0023-17.


Non-invasive imaging cannot replace formal angiography in the diagnosis of renovascular hypertension.

Trautmann A, Roebuck D, McLaren C, Brennan E, Marks S, Tullus K Pediatr Nephrol. 2016; 32(3):495-502.

PMID: 27747454 DOI: 10.1007/s00467-016-3501-7.


The Diagnosis and Treatment of Fibromuscular Dysplasia: An Update for Cardiologists.

Kim E, Serhal M Curr Treat Options Cardiovasc Med. 2016; 18(6):37.

PMID: 27029382 DOI: 10.1007/s11936-016-0460-z.